查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715393

基因检测市场按产品类型、技术、应用、分销管道、最终用户划分－2025-2030 年全球预测

Genetic Testing Market by Product, Test Type, Technology, Application, Distribution Channel, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年基因检测市场规模将达到118.9亿美元，到2024年将以14.01%的复合年增长率成长至135.5亿美元，到2030年将达到297.9亿美元。

主要市场统计数据
基准年2023年 118.9亿美元
预计2024年 135.5亿美元
预测年份 2030 297.9亿美元
复合年增长率（%） 14.01%

基因检测市场正在迅速发展成为一个复杂而充满活力的行业，其特点是技术进步和对个人化医疗的日益重视。在过去的几年里，该行业已经超越了传统的诊断工具，采用了利用硬体和软体相互交织功能的尖端调查方法。随着公司不断创新，新颖的测试通讯协定和强大的分析平台正在融合，为效率和精确度至关重要的复杂市场环境铺平了道路。

最近的趋势不仅扩大了基因检测的范围，而且重新定义了其经济和临床相关性。从简化早期疾病检测到加强预防性医疗保健策略，基因检测市场在塑造全球健康倡议中发挥关键作用。本介绍对市场细分、区域动态以及积极重新定义基因诊断的关键参与者进行了深入研究。在速度、准确性和可靠性决定竞争优势的时代，了解不断变化的情况对于寻求确保行业领先地位的利益相关人员至关重要。

本执行摘要首先概述了塑造该行业的变革性变化，然后分析了细分市场和区域见解，最后提出了有针对性的建议并呼吁行业决策者采取行动。

推动基因检测的转型

近年来，基因检测产业经历了几次变革时期，重塑了公司处理医疗诊断和个人化医疗的方式。技术进步带来的成本降低加速了基因检测与常规临床实务的整合。 DNA定序的创新以及增强的生物资讯工具使得检测方法向快速、全面的转变成为可能，大大缩短了周转时间并提高了结果的整体准确性。

这种转变的关键驱动因素是数位健康平台的日益普及，这些平台简化了资料管理并改善了测试结果的传播。从旧有系统转向云端基础的解决方案的转变不仅实现了即时资料处理，而且还鼓励患者和医疗保健提供者之间更个人化的互动。这一演变得归功于对研发的大量投资，从而带来了基因表现表现谱和精准诊断的突破性进展。

另一个重要趋势是遗传学、肿瘤学和计算生物学等领域跨学科专业知识的整合。这种协作方法有助于将传统实验室业务与尖端技术相结合，以产生以患者为中心且科学合理的创新解决方案。随着市场不断成熟，创新技术与不断发展的临床应用的相互作用凸显了保持领先于现代产业趋势的重要性。这些变革不仅是技术里程碑，也证明了产业领导者采取的适应性策略，继续在该领域树立更高的标准。

基因检测市场的详细細項分析

将基因检测市场细分，可以让我们了解这个快速发展的产业的多面性。从产品创新的角度分析细分，可以发现市场研究分为两大类：消耗品和设备，以及软体和服务。这种双重关注支撑了一个平衡的生态系统，精密硬体和高级分析技术共同发挥作用。

此外，还有基于测试类型的各种评估。该行业将检测能力细分为不同的专业，包括携带者检测和诊断检测以及新生儿筛检测试。此外，市场在药物基因组学创新、胚胎着床前治疗、产前检测、综合征前检测和预测检测方面都出现了显着增长。每种测试类型都提供独特的资料点，可以增加对基因诊断和治疗性介入的信心。

此外，技术细分提供了对基因分析中部署的各种方法的深入了解。细胞遗传学、DNA序列测定和基因表现由微阵列和PCR等先进平台补充。这样的技术频谱确保实验室能够根据其特定的诊断需求选择理想的方法。

基于应用的细分透过关注不同的临床领域（包括自体免疫疾病、癌症、慢性疾病、遗传性疾病和神经退化疾病）进一步使市场策略多样化。市场策略也受到分销管道的影响，同时考虑线下和线上。最后，我们专注于最终用户细分，展示了一系列参与者，包括诊断实验室、家庭环境、医院和诊所。结合这些细分可以提供一个全面的观点，为决策者提供采取有针对性的策略和最大限度地进入市场所需的洞察力。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 遗传疾病和肿瘤疾病的流行以及精准医疗的需求
      • 政府关于基因检测和自我检测套组推广的倡议
    • 限制因素
      • 对基因检测假阳性和假阴性的担忧
    • 机会
      • 基因检测技术的持续研究与新发展
      • 透过远端医疗和数位健康平台进行基因检测的出现
    • 任务
      • 基因检测的后勤障碍与隐私问题
  • 市场区隔分析
    • 产品：用于高效资料管理和分析的通用软体和服务
    • 检测类型：专注于诊断特定疾病的诊断测试
    • 技术：越来越多地转向 DNA定序以实现准确的基因识别和疾病诊断
    • 应用：越来越多地采用基因检测来检测癌症的早期征兆
    • 分销管道：基因检测产品可透过线上平台取得
    • 最终使用者：基因检测解决方案广泛应用于医院和诊所的疾病诊断和治疗计划。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 基因检测市场（依产品）

  • 耗材和设备
  • 软体和服务

第七章 基因检测市场（依检测类型）

  • 职业测试
  • 诊断测试
  • 新生儿筛检
  • 药物基因组学
  • 胚胎着床前测试
  • 产前检查
  • 症状前和预测性检测

第八章 基因检测市场（按技术）

  • 细胞遗传学
  • DNA定序
  • 基因表现
  • 微阵列
  • PCR

第九章 基因检测市场（按应用）

  • 自体免疫疾病
  • 癌症
  • 慢性病
  • 遗传性疾病
  • 神经退化性疾病

第 10 章 基因检测市场（依通路）

  • 离线
  • 在线的

第 11 章 基因检测市场（依最终使用者划分）

  • 诊断实验室
  • 主页设定
  • 医院和诊所

第十二章美洲基因检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

13. 亚太地区基因检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章欧洲、中东和非洲的基因检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023年市场占有率分析
  • 2023年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Bruker Corporation
  • Centogene NV
  • Color Health, Inc.
  • CooperSurgical Inc.
  • Editas Medicine, Inc.
  • Eugene Labs Pty Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Fulgent Genetics, Inc.
  • Gene by Gene, Ltd.
  • GeneDx, LLC
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Living DNA Ltd.
  • Macrogen, Inc.
  • MyHeritage Ltd.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Newtopia Inc.
  • PathogenDx Corporation
  • PerkinElmer Inc.
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • Sanofi SA
  • Thermo Fisher Scientific Inc.
Product Code: MRR-437E9896A512

The Genetic Testing Market was valued at USD 11.89 billion in 2023 and is projected to grow to USD 13.55 billion in 2024, with a CAGR of 14.01%, reaching USD 29.79 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 11.89 billion
Estimated Year [2024] USD 13.55 billion
Forecast Year [2030] USD 29.79 billion
CAGR (%) 14.01%

The genetic testing market has rapidly transformed into a complex and dynamic field, characterized by technological advancements and a growing emphasis on personalized medicine. Over the past few years, this industry has moved beyond traditional diagnostic tools to embrace state-of-the-art methodologies that leverage the intertwined capabilities of hardware and software. As companies continue to innovate, the integration of novel testing protocols with robust analytical platforms has paved the way for a sophisticated market environment where efficiency and precision are paramount.

Recent developments have not only expanded the scope of genetic testing but also redefined its economic and clinical significance. From streamlining early detection of diseases to enhancing preventive healthcare strategies, the market has taken a pivotal role in shaping global health initiatives. This introduction sets the stage for an in-depth exploration of market segmentation, regional dynamics, and the key players that are actively redefining genetic diagnostics. In an era where speed, accuracy, and reliability dictate competitive advantage, understanding the evolving landscape becomes critical for stakeholders looking to secure leadership in the industry.

In this executive summary, we begin by outlining the transformative shifts shaping the field, followed by an analytical breakdown of segmentation and regional insights, and conclude with targeted recommendations and a compelling call-to-action for industry decision-makers.

Driving Transformative Shifts in Genetic Testing

The genetic testing landscape has undergone several transformative shifts over recent years, reshaping the way businesses approach healthcare diagnostics and personalized medicine. Cost reductions, driven by advancements in technology, have accelerated the integration of genetic testing into routine clinical practice. Innovations in DNA sequencing, along with enhanced bioinformatics tools, have enabled a shift towards rapid and comprehensive testing methods, substantially shortening turnaround times and improving the overall accuracy of results.

A critical driver in these shifts is the growing adoption of digital health platforms that simplify data management and improve test result dissemination. The transition from legacy systems to cloud-based solutions has not only enabled real-time data processing but also encouraged more personalized engagement between patients and healthcare providers. This evolution is supported by substantial investments in research and development, which have paved the way for breakthroughs in gene expression profiling and precision diagnostics.

Another pivotal trend involves the integration of multidisciplinary expertise from fields such as genetics, oncology, and computational biology. This collaborative approach has helped merge traditional laboratory practices with advanced technology, creating innovative solutions that are both patient-centric and scientifically robust. As the market continues to mature, the interplay between innovative technology and evolving clinical applications underlines the importance of staying ahead of modern industry trends. These transformative shifts represent not only technological milestones but are also a testament to the adaptive strategies adopted by industry leaders who continue to set higher standards in the field.

In-Depth Segmentation Analysis of the Genetic Testing Market

The segmentation of the genetic testing market provides a lens into the multifaceted nature of this rapidly evolving industry. Analyze the segmentation from a product innovation perspective reveals that the market is studied across two primary categories, spanning consumables and equipment as well as software and services. This dual focus supports a balanced ecosystem where precision hardware and advanced analytics operate in tandem.

Moreover, the evaluation based on test type is extensive. The industry segments its testing capabilities into various specialized areas involving carrier and diagnostic tests along with screenings for newborns. Furthermore, the market has seen significant growth in pharmacogenomic innovations, preimplantation procedures, and both prenatal and presymptomatic as well as predictive testing. Each test type contributes unique data points that collectively enhance the reliability of genetic diagnostics and therapeutic interventions.

In addition, the technological segmentation offers insight into the diverse methodologies deployed in genetic analysis. Cytogenetics, DNA sequencing, and gene expression profiling are complemented by advanced platforms such as microarrays and PCR. Such a technical spectrum ensures that laboratories can select ideal methods based on specific diagnostic needs.

Application-based segmentation further diversifies market strategies by focusing on a range of clinical areas including autoimmune disorders, cancer, chronic diseases, genetic disorders, and neurodegenerative challenges. Market strategies are also influenced by the distribution channels, which consider both offline and online modalities, thereby broadening accessibility. Finally, emphasis on end-user segmentation showcases an array of participants including diagnostic laboratories, home settings, and hospitals and clinics. Together, these layers of segmentation inform a well-rounded perspective, equipping decision-makers with the insights needed to adopt targeted strategies and maximize market reach.

Based on Product, market is studied across Consumables & Equipment and Software & Services.

Based on Test Type, market is studied across Carrier Testing, Diagnostic Testing, New Born Screening, Pharmacogenomics, Preimplantation Testing, Prenatal Testing, and Presymptomatic & Predictive Testing.

Based on Technology, market is studied across Cytogenetics, DNA Sequencing, Gene Expression Profiling, Microarrays, and PCR.

Based on Application, market is studied across Autoimmune Disorders, Cancer, Chronic Diseases, Genetic Disorders, and Neurodegenerative Diseases.

Based on Distribution Channel, market is studied across Offline and Online.

Based on End-User, market is studied across Diagnostic Laboratories, Home Setting, and Hospitals & Clinics.

Regional Market Dynamics Shaping the Genetic Testing Industry

Regional insights into the genetic testing market reveal distinctive trends and opportunities across key global zones. In the Americas, technological advancements have significantly boosted market growth through strengthened healthcare infrastructures and proactive public health policies. Developed healthcare systems, supported by solid governmental frameworks, have accelerated the adoption of genetic diagnostics, particularly in disease prevention and the personalization of medical treatments.

In the region encompassing Europe, the Middle East, and Africa, a blend of high-quality research, robust regulatory frameworks, and emerging market potential defines the landscape. European nations continue to lead in innovation through cutting-edge technological research, while countries in the Middle East and Africa are rapidly embracing genetic testing as part of broader health and diagnostic reforms. This region is witnessing enhanced collaboration between private and public entities to address both economic and clinical gaps in healthcare delivery.

Asia-Pacific is emerging as a formidable force, driven by rapid urbanization, increasing investments in healthcare innovation, and a rapidly growing middle class. The region benefits from significant government initiatives geared towards expanding and modernizing healthcare facilities, thereby fostering an environment conducive to the widespread application of genetic testing services. The varying pace of digital transformation across these regions underscores the importance of tailoring strategies to specific cultural, economic, and regulatory contexts. Collectively, these regional dynamics present a mosaic of promising opportunities for stakeholders aiming to leverage genetic testing technologies for sustainable growth.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insightful Analysis of Leading Companies in Genetic Testing

The competitive landscape of the genetic testing market is defined by an array of leading companies recognized for their contributions to innovation and technological advancements. Industry giants such as Abbott Laboratories and Agilent Technologies, Inc. have long been instrumental in developing sophisticated testing platforms, while companies like Becton, Dickinson and Company and Bio-Rad Laboratories, Inc. continue to push the boundaries of diagnostic precision through their integrated solutions. These leaders, alongside firms such as Bio-Techne Corporation and Bruker Corporation, have set new standards in both the reliability and scalability of genetic assays.

Centogene N.V. and Color Health, Inc. are also contributing to more targeted and accessible genetic testing, ensuring that breakthroughs in diagnosis are rapidly translated into clinical practice. CooperSurgical Inc. and Editas Medicine, Inc. exemplify the next wave of innovation by enhancing both surgical precision and gene-editing techniques. Meanwhile, smaller players like Eugene Labs Pty Ltd. and Eurofins Scientific SE are expanding market reach through localized expertise and nimble operational frameworks.

Other notable players including F. Hoffmann-La Roche AG, Fulgent Genetics, Inc., Gene by Gene, Ltd. and GeneDx, LLC have carved niches by specializing in tailored diagnostic and therapeutic solutions. The vision of these companies is further supported by major contributions from industry leaders such as Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, and Living DNA Ltd., who continue to drive advancements in sequencing technology and genetic analytics. Additional notable participants such as Macrogen, Inc., MyHeritage Ltd., Myriad Genetics, Inc., Natera, Inc., Newtopia Inc., and PathogenDx Corporation round out the landscape. Pioneering efforts by PerkinElmer Inc., Qiagen N.V., Quest Diagnostics Incorporated, Sanofi S.A., and Thermo Fisher Scientific Inc. further reinforce a competitive environment characterized by relentless technological progress and market-driven innovation. The collective influence of these companies not only shapes present market trends but also sets the stage for future advancements in genetic testing.

The report delves into recent significant developments in the Genetic Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Bruker Corporation, Centogene N.V., Color Health, Inc., CooperSurgical Inc., Editas Medicine, Inc., Eugene Labs Pty Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fulgent Genetics, Inc., Gene by Gene, Ltd., GeneDx, LLC, Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Living DNA Ltd., Macrogen, Inc., MyHeritage Ltd., Myriad Genetics, Inc., Natera, Inc., Newtopia Inc., PathogenDx Corporation, PerkinElmer Inc., Qiagen N.V., Quest Diagnostics Incorporated, Sanofi S.A., and Thermo Fisher Scientific Inc.. Actionable Recommendations to Drive Market Leadership

For industry leaders navigating the evolving genetic testing market, adopting a forward-thinking strategy is imperative. Decision-makers are advised to embrace technology integration as a focal point of growth, leveraging advancements in both hardware and analytical software to streamline testing processes. By investing in state-of-the-art diagnostic tools and fostering partnerships that promote innovation, companies can secure a competitive edge in a rapidly evolving healthcare ecosystem.

It is essential to ensure that research and development activities remain aligned with emerging market trends, particularly in areas like gene expression profiling, DNA sequencing, and advanced bioinformatics. An active focus on diversifying testing methods to cover a broader range of applications-including autoimmune disorders, cancer, and neurodegenerative diseases-can not only enhance diagnostic accuracy but also increase market penetration. Collaborations with technological firms and academic institutions can facilitate the development of robust testing protocols that meet stringent regulatory requirements while addressing unmet clinical needs.

Furthermore, regional tailoring of market strategies can amplify impact. Leaders should consider localized strategies to capitalize on the unique dynamics of the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions. By aligning operational frameworks with regional healthcare needs and regulatory landscapes, companies can optimize resource allocation and streamline market entry. Finally, enhancing the digital ecosystem through cloud-based analytics and tele-diagnostic services can further democratize access to high-quality genetic testing. These actionable recommendations are set to empower industry leaders to not only maintain but also extend their influence in this dynamic market.

Concluding Thoughts on the Future of Genetic Testing

In conclusion, the genetic testing market represents a blend of rapid technological innovation, expansive segmentation strategies, and regionally diverse opportunities. The progress made over the recent years is indicative of an industry that is transforming from a niche service into a mainstream component of personalized healthcare. The intricate interplay between emerging technologies and robust market segmentation ensures that the market remains vibrant, with competitive differentiation driven by both product innovation and strategic geographic targeting.

The analysis presented here underscores the importance of a well-rounded market approach-one that synergizes technological advancements with deep industry insights and regional trends. As the industry continues to evolve, staying adaptable and harnessing the potential of innovations ranging from advanced sequencing methods to integrated data analytics will determine the success of market leaders. The roadmap outlined in this summary provides comprehensive guidance that will support the sustained growth and strategic dominance of companies investing in genetic testing.

Looking forward, the momentum in research and development is likely to accelerate further breakthroughs, thereby expanding the clinical applications of genetic diagnostics. Decision-makers who invest in technology, nurture key partnerships, and integrate cross-regional strategies will be best positioned to lead in this forward-thinking market. The future of genetic testing is not only bright but poised for disruptive reinvention, creating endless possibilities for elevating healthcare outcomes through precision diagnostics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of genetic and oncology disorders and the need for precision medicine
      • 5.1.1.2. Government initiatives for genetic testing and the rise of self-test kits
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with false positives and negatives of genetic tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and new developments in genetic testing technologies
      • 5.1.3.2. Emergence of genetic testing with telehealth and digital health platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Logistical barriers and privacy concerns to genetic testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Penetration of software and services for efficient data management and analysis
    • 5.2.2. Test Type: Emphasis on diagnostic testing to perform a particular disease diagnosis
    • 5.2.3. Technology: Increasing shift toward DNA sequencing for precise gene identification and disease diagnosis
    • 5.2.4. Application: Rising adoption of genetic testing to detect early signs of cancer
    • 5.2.5. Distribution Channel: Deployment of genetic testing products on online platforms
    • 5.2.6. End-User: Extensive use of genetic testing solutions in hospitals & clinics for disease diagnosis and treatment planning
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genetic Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables & Equipment
  • 6.3. Software & Services

7. Genetic Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Carrier Testing
  • 7.3. Diagnostic Testing
  • 7.4. New Born Screening
  • 7.5. Pharmacogenomics
  • 7.6. Preimplantation Testing
  • 7.7. Prenatal Testing
  • 7.8. Presymptomatic & Predictive Testing

8. Genetic Testing Market, by Technology

  • 8.1. Introduction
  • 8.2. Cytogenetics
  • 8.3. DNA Sequencing
  • 8.4. Gene Expression Profiling
  • 8.5. Microarrays
  • 8.6. PCR

9. Genetic Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Autoimmune Disorders
  • 9.3. Cancer
  • 9.4. Chronic Diseases
  • 9.5. Genetic Disorders
  • 9.6. Neurodegenerative Diseases

10. Genetic Testing Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Genetic Testing Market, by End-User

  • 11.1. Introduction
  • 11.2. Diagnostic Laboratories
  • 11.3. Home Setting
  • 11.4. Hospitals & Clinics

12. Americas Genetic Testing Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Genetic Testing Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Genetic Testing Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Sysmex and QIAGEN strengthen alliance to advance genetic testing innovation
    • 15.3.2. Labcorp Finalizes Acquisition of Key Invitae Assets in Strategic Expansion
    • 15.3.3. Labcorp and Ultima Genomics partnership advances affordable genomic insights for oncology testing
    • 15.3.4. MedGenome expands its influence through strategic acquisition in east India's genetic testing landscape
    • 15.3.5. Bruker Corporation Expanded Diagnostic Capabilities with EUR 870 Million Acquisition of ELITechGroup SAS, Enhancing Molecular and Microbial Testing
    • 15.3.6. Devyser AB Unveiled New Genetic Testing Products to Improve Cancer Risk Analysis
    • 15.3.7. Blueprint Genetics Oy Offers Advanced Testing Solutions for Informed Family Planning Decisions
    • 15.3.8. Kindbody Unveiled Affordable, High-Quality Genetic Testing Division Kindlabs for Enhanced Pregnancy Success
    • 15.3.9. Delve Bio, Inc. Secureed USD 35 Million Funding to Unveil Causes of Neurological Inflammation Through Advanced Pathogen Detection
    • 15.3.10. FBI Approved QIAGEN N.V.'s Advanced Forensic DNA Testing Workflow for Use in National Crime Database
    • 15.3.11. healthOme, Inc. Acquired Kailos Genetics, Inc., to Enhance Genetic Testing Services for Cancer Risk and Medication Safety
    • 15.3.12. BeautyMap Launched DNA-Based Skincare and Haircare Test In India
    • 15.3.13. CENTOGENE N.V. and Takeda Pharmaceutical Company Limited Extend Partnership to Enhance Diagnostic Testing for Rare Diseases Globally
    • 15.3.14. Invitae Corporation and Epic Systems Corporation Joined Forces to Streamline Genetic Test Results, Enhancing Access for Healthcare Providers
    • 15.3.15. Agilent Technologies Inc. Expanded Clinical Research Capabilities with Acquisition of Avida Biomed
  • 15.4. Strategy Analysis & Recommendation
    • 15.4.1. Natera, Inc.
    • 15.4.2. F. Hoffmann-La Roche AG
    • 15.4.3. Thermo Fisher Scientific Inc.
    • 15.4.4. Illumina, Inc.

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bio-Techne Corporation
  • 6. Bruker Corporation
  • 7. Centogene N.V.
  • 8. Color Health, Inc.
  • 9. CooperSurgical Inc.
  • 10. Editas Medicine, Inc.
  • 11. Eugene Labs Pty Ltd.
  • 12. Eurofins Scientific SE
  • 13. F. Hoffmann-La Roche AG
  • 14. Fulgent Genetics, Inc.
  • 15. Gene by Gene, Ltd.
  • 16. GeneDx, LLC
  • 17. Illumina, Inc.
  • 18. Invitae Corporation
  • 19. Laboratory Corporation of America Holdings
  • 20. Living DNA Ltd.
  • 21. Macrogen, Inc.
  • 22. MyHeritage Ltd.
  • 23. Myriad Genetics, Inc.
  • 24. Natera, Inc.
  • 25. Newtopia Inc.
  • 26. PathogenDx Corporation
  • 27. PerkinElmer Inc.
  • 28. Qiagen N.V.
  • 29. Quest Diagnostics Incorporated
  • 30. Sanofi S.A.
  • 31. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GENETIC TESTING MARKET MULTI-CURRENCY
  • FIGURE 2. GENETIC TESTING MARKET MULTI-LANGUAGE
  • FIGURE 3. GENETIC TESTING MARKET RESEARCH PROCESS
  • FIGURE 4. GENETIC TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENETIC TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENETIC TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 287. GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 288. GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023